DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Rotigotine

Rotigotine

  • Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission

    Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission

  • The Use of Illicit Drugs As Self-Medication in the Treatment of Cluster Headache: Results from an Italian Online Survey

    The Use of Illicit Drugs As Self-Medication in the Treatment of Cluster Headache: Results from an Italian Online Survey

  • Endogenous Metabolites in Drug Discovery: from Plants to Humans

    Endogenous Metabolites in Drug Discovery: from Plants to Humans

  • Crystal Structure of Dopamine D1 Receptor in Complex with G Protein and a Non-Catechol Agonist

    Crystal Structure of Dopamine D1 Receptor in Complex with G Protein and a Non-Catechol Agonist

  • An Improved Validated Ultra High Pressure Liquid Chromatography Method for Separation of Rotigotine Impurities in Rotigotine Transdermal Patch

    An Improved Validated Ultra High Pressure Liquid Chromatography Method for Separation of Rotigotine Impurities in Rotigotine Transdermal Patch

  • WO 2009/147681 Al

    WO 2009/147681 Al

  • In-Silico Approaches

    In-Silico Approaches

  • Neupro® (Rotigotine Transdermal System) Is a Transdermal Delivery System That Provides 7 Rotigotine, a Non-Ergolinic Dopamine Agonist

    Neupro® (Rotigotine Transdermal System) Is a Transdermal Delivery System That Provides 7 Rotigotine, a Non-Ergolinic Dopamine Agonist

  • Acute Management of In-Patient Parkinson's Disease Patients

    Acute Management of In-Patient Parkinson's Disease Patients

  • Prescription Medications, Drugs, Herbs & Chemicals Associated With

    Prescription Medications, Drugs, Herbs & Chemicals Associated With

  • Behavioral Pharmacology of Dopamine D2 and D3 Receptor Agonists and Antagonists in Rats

    Behavioral Pharmacology of Dopamine D2 and D3 Receptor Agonists and Antagonists in Rats

  • Side Effects of a Dopamine Agonist Therapy for Parkinson's Disease

    Side Effects of a Dopamine Agonist Therapy for Parkinson's Disease

  • Nervous System Drug Poster

    Nervous System Drug Poster

  • Management of Parkinson's Disease During Periods of Fasting

    Management of Parkinson's Disease During Periods of Fasting

  • Neupro, INN-Rotigotine

    Neupro, INN-Rotigotine

  • New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A

    New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A

  • Appendix B - Product Name Sorted by Applicant

    Appendix B - Product Name Sorted by Applicant

  • Effect of Rotigotine Vs Placebo on Cognitive Functions Among Patients with Mild to Moderate Alzheimer Disease a Randomized Clinical Trial

    Effect of Rotigotine Vs Placebo on Cognitive Functions Among Patients with Mild to Moderate Alzheimer Disease a Randomized Clinical Trial

Top View
  • NHSGGC Formulary 4Th Edition August 2010
  • Rotigotine Patches (Neupro®) in the Treatment of Parkinson's Disease
  • Open Leesang-Min-Doctoral Dissertation
  • Impulse Control Disorders in Patients with Hyperpolactinemia Treated With
  • New Evidence for Reduced Leg Oxygen Levels in Restless Legs Syndrome Erik K
  • PATIENT INFORMATION NEUPRO® [NU Pro] (Rotigotine Transdermal System)
  • Australian Public Assessment Report for Rotigotine
  • Lysergic Acid Diethylamide As a Multi-Target Therapeutic for Alzheimer’S Disease
  • Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey I
  • Parkinson's Disease in Acute Care
  • FEP 5 Tier Rx Drug Formulary (607) Standard Option
  • Novel Pharmacological Targets for the Treatment of Parkinson's Disease
  • Overview of Parkinson's Disease Treatment Options
  • Cognitive Enhancement in Psychiatric Disorders
  • Emergencies and Critical Issues in Parkinson's Disease
  • Neupro, INN-Rotigotine
  • Neupro (Rotigotine)
  • Efficacy of Rotigotine at Different Stages Of


© 2024 Docslib.org    Feedback